Skip To Main Content
Masujiro Makita on Muck Rack

Masujiro Makita

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Masujiro

Contact Masujiro, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cellular variant focal segmental glomerulosclerosis during trastuzumab emtansine treatment in HER2-positive breast cancer: a case report

|
By Sae Aratani, Daisuke Miyamoto, Hideko Hoshina, Yukako Shintani-Domoto, Tetsuya Kashiwagi, Ryuji Ohashi, Masato Iwabu, Soshi Okada, Masujiro Makita, Risa Murasato, Akio Hirama
| Frontiers
Abstract Onconephrology is an emerging subspecialty that encompasses comprehensive kidney management in patients with cancer. Trastuzumab emtansine (T-DM1) is an antibody–drug conjugate composed of trastuzumab linked to the microtubule inhibitor. T-DM1 is widely used in the treatment of human epidermal growth factor receptor 2-positive breast cancer, and glomerular disease arising during T-DM1 therapy remains rarely reported.
Open in Who Shared Issue with article?
See all 1 articles